Navigation Links
Fighting bacteria's strength in numbers
Date:5/17/2012

Scientists at The University of Nottingham have opened the way for more accurate research into new ways to fight dangerous bacterial infections by proving a long-held theory about how bacteria communicate with each other.

Researchers in the University's School of Molecular Medical Sciences have shown for the first time that the effectiveness of the bacteria's communication method, a process called 'quorum sensing', directly depends on the density of the bacterial population. This work will help inform wider research into how to stop bacteria talking to each other with the aim of switching off their toxin production.

As some pathogenic organisms are increasingly resistant to traditional antibiotics, medical researchers around the world, including scientists at The University of Nottingham, are trying to find other ways of fighting infection. This new work involves using 'quorum quenching' compounds which interfere with bacterial signalling and disrupt their social lives.

Quorum sensing (QS) is the process by which bacteria communicate and co-operate using signal molecules which control, among other things, the production of toxins. QS is therefore an important factor in a number of bacterial species that cause serious infection in humans including Pseudomonas aeruginosa, a leading cause of death among cystic fibrosis sufferers, and MRSA which is a huge clinical problem in hospitals.

Leading the research at Nottingham, Dr Stephen Diggle said: "The fundamental assumption used to explain QS, is that the production of QS-controlled factors is not beneficial until a sufficient density of cells (a quorum) is present, and that the purpose of QS is to stimulate social behaviours only when high enough bacterial population densities are reached. For a pathogen this makes sense. Why produce toxins when there are not many cells around? Why not wait until a large number are present and coordinate production of toxin on mass which helps to overwhelm a host? This density assumption, upon which the entire QS field is based, has never been experimentally tested until now."

This ground-breaking research has just been published in the leading international journal, Proceedings of the National Academy of Sciences. It shows for the first time that cell density is an important factor in regulating QS in the opportunistic pathogen Pseudomonas aeruginosa. Using a combination of special growth media and molecular techniques, the work has shown that QS signalling occurs in low populations of cells but that there is no benefit to the bacteria of doing so. QS is therefore most useful to the bacteria at high cell densities.

A challenge for researchers in the future is to study this in more natural environments such as infections. Bacteria such as P. aeruginosa use QS to control toxin production and this new research helps to explain how certain infections can suddenly turn life threatening due to massive toxin release. This suggests that carefully controlling bacterial population density within infections could be helpful in avoiding toxin-related damage.


'/>"/>

Contact: Emma Rayner
emma.rayner@nottingham.ac.uk
44-115-951-5793
University of Nottingham
Source:Eurekalert  

Related biology news :

1. UCSB study finds physical strength, fighting ability revealed in human faces
2. Children distressed by family fighting have higher stress hormones
3. Wistar scientists find key to keeping killer T cells in prime shape for fighting infection, cancer
4. Fighting obesity and illness with a novel approach to nutrition
5. Fighting global warming offers growth and development opportunities
6. Novel lung cancer vaccine shows promise in fighting early-stage lung cancer
7. Rabbits on the back foot -- but naturally theyre fighting back
8. U-Iowa improves delivery of cancer-fighting molecules
9. Fighting the burden of mental disorders
10. Master gene that switches on disease-fighting cells identified by scientists
11. Georgia State researcher to use $1 million grant to improve computer models for fighting wildfires
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Fighting bacteria's strength in numbers
(Date:3/22/2017)... , March 21, 2017 ... Cloud used by retailers such as 1-800-Flowers and ... platform — Product Recommendations and Replenishment. Using Optimove,s machine ... more personalized product and replenishment recommendations to their ... also on predictions of customer intent drawn from ...
(Date:3/20/2017)... March 20, 2017 At this year,s CeBIT Chancellor ... biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG stand together with ... this year,s CeBIT partner country. At the largest German biometrics company the ... fingerprint, face and iris recognition as well as DERMALOG´s multi-biometrics system.   ... ...
(Date:3/16/2017)... -- CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made in ... ... Used combined in one project, multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog ... Used combined in one project, multi-biometric solutions provide ... ...
Breaking Biology News(10 mins):
(Date:4/20/2017)... ... April 20, 2017 , ... NetDimensions appoints Bill Mastin, a learning technology veteran, ... of experience in the learning technologies industry, Mastin joins NetDimensions from the New York ... plc (LTG). At LEO, Mastin served as SVP of the North America offices and ...
(Date:4/20/2017)... ... April 20, 2017 , ... ... unique intellectual property (IP) sharing and commercialization model. , The Center for Advancing ... main component of this effort is bringing the IP to the attention of ...
(Date:4/19/2017)... ... April 18, 2017 , ... ... been a key device for generating monodisperse droplets of known diameters for research ... for generating monodisperse solid particles by drying monodisperse droplets. , The VOAG ...
(Date:4/19/2017)... ... ... Nobilis Therapeutics Announces Completion of Landmark NBTX-001 Clinical Trial in ... Upcoming Post Traumatic Stress Disorder Trial , Nobilis Therapeutics, Inc. announced today ... its NBTX-001, a xenon-based therapeutic in the treatment of Panic Disorder. , ...
Breaking Biology Technology: